FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/085791 [Registered on: 28/04/2025] Trial Registered Prospectively
Last Modified On: 25/04/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   To study the effect of Panchakoladi Churna in decreasing recurrent nasal discharge in children age 2 year to 12 years. 
Scientific Title of Study   Evaluation of the Efficacy of Panchakoladi Churna in Peenasa (Rhinitis) in Children 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Unmesh Khushalgir Gosavi 
Designation  MD Scholar 
Affiliation  Dr. D. Y. Patil College of Ayurved and Research Centre 
Address  OPD No.1 and IPD Kaumarbhritya Department, Dr. D. Y. Patil College of Ayurved and Research Centre, Sant Tukaram Nagar, Pimpri, Pune, Maharashtra 411018

Pune
MAHARASHTRA
411018
India 
Phone  8600484367  
Fax    
Email  gosaviunmesh@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Ravindra Rajpal 
Designation  Professor 
Affiliation  Dr. D. Y. Patil College of Ayurved and Research Centre 
Address  OPD No.1 and IPD Kaumarbhritya Department, Dr. D. Y. Patil College of Ayurved and Research Centre, Sant Tukaram Nagar, Pimpri, Pune, Maharashtra 411018

Pune
MAHARASHTRA
411018
India 
Phone  9922037201  
Fax    
Email  ravirajpal24@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Ravindra Rajpal 
Designation  Professor 
Affiliation  Dr. D. Y. Patil College of Ayurved and Research Centre 
Address  OPD No.1 and IPD Kaumarbhritya Department, Dr. D. Y. Patil College of Ayurved and Research Centre, Sant Tukaram Nagar, Pimpri, Pune, Maharashtra 411018


MAHARASHTRA
411018
India 
Phone  9922037201  
Fax    
Email  ravirajpal24@gmail.com  
 
Source of Monetary or Material Support  
Dr. D. Y. Patil College of Ayurved and Research Centre, Sant Tukaram Nagar, Pimpri, Pune, Maharashtra 411018 
 
Primary Sponsor  
Name  Dr Unmesh Khushalgir Gosavi 
Address  Dr. D. Y. Patil College of Ayurved and Research Centre, Sant Tukaram Nagar,Pimpri, Pune Maharashtra 411018 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Unmesh Khushalgir Gosavi  Dr. D. Y. Patil College of Ayurved and Research Centre  OPD & IPD, Kaumarbhritya Department, Dr. D. Y. Patil College of Ayurved and Research Centre, Sant Tukaram Nagar, Pimpri, Pune Maharashtra 411018 Pune MAHARASHTRA
Pune
MAHARASHTRA 
8600484367

gosaviunmesh@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
DR DYPCA & RC INSTITUTIONAL ETHICS COMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:J310||Chronic rhinitis. Ayurveda Condition: PINAS,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: PANCHAKOLADI CHURNA , Reference: ASTANGA SAMGRAHA BY PROF JYOTIR MITRA CHOUKHAMBA SURABHARTI PUBLICATION VARANASI UTTARASTHANA CHAPTER NO 2 SHLOK NO 56 AND GADA NIGRAHA KAYACHIKITSA KHANDA KAUMARTANTRA BALROGADHIKAR CHAPTER NO 11 SHLOK NO 112, Route: Oral, Dosage Form: Churna/ Powder, Dose: 1(g), Frequency: tds, Bhaishajya Kal: Pragbhakta, Duration: 7 Days, anupAna/sahapAna: Yes(details: -MADHU), Additional Information: -
 
Inclusion Criteria  
Age From  2.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  1. The patients having at least 2 – 3 symptoms of Peenasa are as follows-
a.NASASTRAVA (Rhinorrhea)
b.KSHAVATHU (Sneezing)
c.NASAVARODHA (Nasal congestion)
d.NASAKANDU (Itching in nose)
e.SHIRASHOOLA (Headache)
2.The patients of age from 2 year to 12 years.
3.The patients who’s parents are ready to participate in the clinical trial by giving informed written consent.
 
 
ExclusionCriteria 
Details  1. Patients and his/her parents/guardian not willing for trial
2. Patients known case of any major chronic illness and any congenital anomalies .
3. Patient who need surgical and other intervention
4. Patients presenting with symptoms of Dushta Peenasa/ Pratishyaya and Raktaga Pratishyaya
5. Patients suffering with other Nasal diseases like Nasal Polyps, Deviated Nasal Septum
6. Patients associated with Nasal Malignancy. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
The Symptoms Of Peenasa Are Expected To Be Reduced After The Use Of Panchakoladi Churna In Childrens.  07 days study with follow up on 03rd and 07th day (0,03,07 days) 
 
Secondary Outcome  
Outcome  TimePoints 
To study the adverse effect of Panchakoladi Churna ,if any  07 days study with follow up on 03rd and 07th day (0,03,07 days) 
 
Target Sample Size   Total Sample Size="45"
Sample Size from India="45" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   10/05/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a single arm clinical study in which the medicine "Panchakoladi Churna " will be provided to 45 patients showing sign and symptoms of Peenasa (Rhinitis). 
 The age group taken for the study trial will be in between 2 years to 12 years. 
 Panchakoladi Churna with Madhu will be given on 0th day thrice a day for 07 days. 
 Dose will be calculated by age formula. Follow up will be done on 3rd and 07th day and the total duration of case study will be 07 days. 
 The final conclusion will be drawn on the basis of statistical methods
 
Close